Drug recall · October 30, 2019
PF-Fentanyl Citrate recall
Why: GMP Deviations: potential glass contamination
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25
- Lots / codes
Lots: FB9001 A Exp. 10/31/2019, FB9001B Exp. 10/31/2019; FB9013A Exp. 12/08/2019; FB9015A Exp. 12/14/2019
- Quantity
- 1855 bags
- Company
- Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, West Columbia, SC
- Distribution
- Nationwide.
- Initiated
- October 9, 2019 · Voluntary: Firm initiated
- Classified
- October 18, 2019
- Reported
- October 30, 2019
- Ended
- December 1, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupivacaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.